Wp. Melega et al., LONGITUDINAL BEHAVIORAL AND 6-[F-18]FLUORO-L-DOPA-PET ASSESSMENT IN MPTP-HEMIPARKINSONIAN MONKEYS, Experimental neurology, 141(2), 1996, pp. 318-329
Biochemical and behavioral criteria were established to determine the
long-term stability of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
(MPTP)-induced unilateral striatal dopamine deficiency in the vervet m
onkey. At time points over a 12-month period, post-MPTP striatal dopam
ine synthesis capacity was indexed with 6-[F-18]fluoro-L-DOPA (FDOPA)-
positron emission tomography. For the MPTP-treated subjects (n = 4), a
n intrasubject FDOPA influx rate constant (K-i) ratio method of right
(lesioned) striatum/left (unlesioned) striatum values was used to asse
ss changes in striatal activity. Striatal FDOPA K-i ratios differed le
ss than 5% between studies conducted at 1-2, 5-7, and 9-11 months post
-MPTP; these results indicated a stable MPTP-induced striatal lesion o
ver this time period. At the 5-7 and 9-11 month time points, behaviora
l indices of the MPTP-induced deficits were obtained within a species-
typical group setting, For three of the four subjects, persistent decr
ements in motoric, affiliative, and vigilance behavior were observed w
hile the frequency of aggression toward group members was increased. A
t the 9-11 month time point, one subject showed a 30% improvement in t
he social measures, indicative of a partial recovery from the MPTP-ind
uced behavioral decrements although its striatal FDOPA K-i ratio remai
ned unchanged. Thus, behavioral and noninvasive biochemical methods ca
n provide complementary indices to assess individual differences in se
nsitivity to MPTP-induced deficits. Both types of data are required to
determine lesion stability and, subsequently, the efficacy of interve
ntions designed to restore normal function in this primate Parkinsonia
n model. (C) 1996 Academic Press, Inc.